1-14 of 14
Denise Wolleschak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Firstline Treatment with Ruxolitinib Versus Best Available Therapy in Patients with Polycythemia Vera: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)

Steffen Koschmieder, Susanne Isfort, Lino L. Teichmann, Philippe Schafhausen, Florian Heidel, Andreas Hochhaus, Martin Griesshammer, Katja Sockel, Philipp Jost, Denise Wolleschak, Konstanze Döhner, Joachim R. Goethert, Markus P. Radsak, Marinela Augustin, Heiko Becker, Aristoteles Giagounidis, Markus Schaich, Martine Klausmann, Nikolas Von Bubnoff, Frank Stegelmann, Maike Kortmann, Julia Frank, Martin Hellmich, Tim H. Brümmendorf
Journal: Blood
Blood (2023) 142 (Supplement 1): 619.
https://doi.org/10.1182/blood-2023-173225
Published: 2023
Journal Articles

Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)

Steffen Koschmieder, Susanne Isfort, Florian H. Heidel, Andreas Hochhaus, Heiko Becker, Philipp J. Jost, Philippe Schafhausen, Martin Griesshammer, Denise Wolleschak, Mathias Haenel, Joachim R Göthert, Lino L. Teichmann, Katja Sockel, Markus P. Radsak, Andreas Reiter, Konstanze Döhner, Sebastian Balleisen, Nadja Jaekel, Nikolas von Bubnoff, Frank Stegelmann, Deniz Gezer, Maike Kortmann, Julia Frank, Martin Hellmich, Tim H. Brümmendorf
Journal: Blood
Blood (2022) 140 (Supplement 1): 1790–1793.
https://doi.org/10.1182/blood-2022-157265
Published: 2022
Journal Articles

Genomic Landscape and Molecular Risk in Patients with Advanced Myelofibrosis Treated within the Multicenter Phase Ib/II MPNSG0212 (POMINC) Trial

Ekaterina Panina, Steffen Koschmieder, Florian H. Heidel, Andreas Hochhaus, Holger Hebart, Susanne Isfort, Frank G. Rücker, Andreas Reiter, Markus Bangerter, Cornelius Waller, Christoph Scheid, Denise Wolleschak, Joachim R. Goethert, Philippe Schafhausen, Thomas Kindler, Markus P. Radsak, Norbert Gattermann, Robert Möhle, Nikolas von Bubnoff, Tim H Brümmendorf, Hartmut Döhner, Martin Griesshammer, Frank Stegelmann, Konstanze Döhner
Journal: Blood
Blood (2021) 138 (Supplement 1): 4637.
https://doi.org/10.1182/blood-2021-150361
Published: 2021
Journal Articles

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Friederike Bachmann, MD, Swantje Held, Monika Engelhardt, MD, Christian Langer, MD, Denise Wolleschak, Janik Fleissner, Lars-Olof Mügge, MD, Heinz Duerk, MD PhD, Martin Schreder, MD, Kerstin Schaefer-Eckart, MD, Igor-Wolfgang Blau, MD PhD, Martin Gramatzki, MD, Peter Liebisch, MD, Albrecht Reichle, MD, Ivana Metzler, MD, Florian Bassermann, MD PhD, Bernd Metzner, MD PhD, Christoph Röllig, MD MSC, Bernd Hertenstein, Tobias Dechow, Wolfram Jung, MD, Helmut Ostermann, MD, Holger Hebart, Georg Maschmeyer, MD, Hans Jürgen Salwender, MD, Marie von Lilienfeld-Toal, MD, Kai-Uwe Eckardt, MD, Christian Straka, MD PhD, Hermann Einsele, MD, Stefan Knop
Journal: Blood
Blood (2019) 134 (Supplement_1): 1840.
https://doi.org/10.1182/blood-2019-125235
Published: 2019
Journal Articles

Ruxolitinib Shows Efficacy in Patients with Newly-Diagnosed Polycythemia Vera: Futility Analysis of the Randomized Ruxo-BEAT Clinical Trial of the German Study Group for Myeloproliferative Neoplasms

Steffen Koschmieder, Susanne Isfort, Dominik Wolf, Univ. Prof. Dr., Florian H. Heidel, Philippe Schafhausen, Martin Griesshammer, MD, Denise Wolleschak, Uwe Platzbecker, Konstanze Döhner, Philipp J. Jost, MD, Stefani B. Parmentier, Nikolas von Bubnoff, Frank Stegelmann, MD, Angela Maurer, Jeremy Franklin, Martina Crysandt, MD, Deniz Gezer, Martin Hellmich, Tim H Brümmendorf, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2944.
https://doi.org/10.1182/blood-2019-123985
Published: 2019
Journal Articles

Updated Results from the German Mpnsg-0212 Combination Trial: Ruxolitinib Plus Pomalidomide in Myelofibrosis with Anemia

Frank Stegelmann, MD, Steffen Koschmieder, Susanne Isfort, Andreas Hochhaus, MD, Florian H. Heidel, Holger Hebart, Markus Bangerter, Denise Wolleschak, Christoph Scheid, MD, Joachim R Göthert, PD, MD, Philippe Schafhausen, Thomas Kindler, MD, Markus P. Radsak, MD, Robert Möhle, MD, Cornelius Waller, Nikolas von Bubnoff, Andreas Reiter, Hartmut Döhner, MD, Martin Griesshammer, MD, Konstanze Döhner
Journal: Blood
Blood (2019) 134 (Supplement_1): 672.
https://doi.org/10.1182/blood-2019-127859
Published: 2019
Journal Articles

Lenalidomide, Adriamycin and Dexamethasone (RAD) Versus Bortezomib, Lenalidomide and Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) - Post-Induction Response and MRD Results By Flow Cytometry and NGS from a Phase 3 Randomized Controlled Clinical Trial (RCT)

Thomas Stübig, MD, Christian Langer, MD, Monika Engelhardt, MD, Lars-Olof Mügge, MD, Florian Bassermann, MD PhD, Martin Schreder, MD, Kerstin Schäfer-Eckart, MD, Igor Wolfgang Blau, Denise Wolleschak, Albrecht Reichle, MD, Ivana Metzler, MD, Bernd Metzner, MDPhD, Christoph Rollig, MD MSC, Bernd Hertenstein, MD, Heinz Dürk, Harald Biersack, MD, Helge Menzel, MD, Tobias Dechow, Jan Schleicher, Martin Gramatzki, MD, Tim H. Brümmendorf, MD, Stephan Fuhrmann, Max Bittrich, MD, Franziska Appelt, Martina Müller, Jan Krönke, MD, Julia Reusch, Christian Schmidt, MD, Monika Brüggemann, MD, Swantje Held, Stefan Knop, Hermann Einsele, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1979.
https://doi.org/10.1182/blood-2018-99-116067
Published: 2018
Journal Articles

Improved Safety with the Use of Subcutaneous Bortezomib in Combination with Panobinostat and Dexamethasone: Preliminary Data from a Panobinostat Global Expanded Treatment Protocol

Andreas Guenther, MD, Lars-Olof Mügge, Mathias Haenel, MD, Fredrik H. Schjesvold, MD, Daniel Lechner, Sameer Yaser, Holger Hebart, MD, Heinz Gisslinger, Richard Greil, MD, Eberhard Gunsilius, MD, Martin Goerner, MD, Katja Weisel, Jan Dürig, MD, Mohamed Elemary, MD MSc,PhD, Denise Wolleschak, Stefan A. Klein, MD, Markus Munder, MD, Alexander Kiani, Hareth Nahi, Christian Junghanss, MD, Valerie Campello-Iddison, MD, Ythier Deniau, Xiaoshu Feng, Hermann Einsele, MD
Journal: Blood
Blood (2016) 128 (22): 5692.
https://doi.org/10.1182/blood.V128.22.5692.5692
Published: 2016
Journal Articles

Ruxolitinib Plus Pomalidomide in Myelofibrosis: Updated Results from the Mpnsg-0212 Trial (NCT01644110)

Frank Stegelmann, MD, Holger Hebart, MD, Markus Bangerter, MD, Denise Wolleschak, Martin Griesshammer, MD, Steffen Koschmieder, MD, Nikolas von Bubnoff, MD, Robert Möhle, MD, Thomas Kindler, MD, Andreas Hochhaus, MD, Florian H. Heidel, MD, Andreas Reiter, MD, Christof Scheid, MD PhD, Rebecca Kirschbaum, Regina Reim, Ulrike Sutter, Katrin Vetter, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2016) 128 (22): 1939.
https://doi.org/10.1182/blood.V128.22.1939.1939
Published: 2016
Journal Articles

Chronic myelogenous leukemia evolving after treatment of multiple myeloma

Denise Wolleschak, Florian H. Heidel
Journal: Blood
Blood (2016) 128 (1): 146.
https://doi.org/10.1182/blood-2016-03-706945
Published: 2016
Journal Articles

Inflammation Induced Expression of Ybx1 Mediates Resistance to JAK-Kinase Inhibitor Therapy in Myeloproliferative Neoplasia

Carolin Herzog, Anja Polanetzki, Stephanie Frey, Tina M Schnoeder, PhD, Denise Wolleschak, MD, Nomusa Mashamba, MSc, Veera Raghavan Thangapandi, Kathleen Jentsch-Ullrich, MD, Christoph Kahl, MD, Nicolas Schroeder, MD, Peter R Mertens, MD, Thomas Fischer, MD, Florian H Heidel, MD
Journal: Blood
Blood (2014) 124 (21): 161.
https://doi.org/10.1182/blood.V124.21.161.161
Published: 2014
Journal Articles

Specificity of JAK-Kinase Inhibition Determines Impact on T-Cell Function

Florian Perner, Felix C Saalfeld, cand.MD, Tina M Schnoeder, PhD, Denise Wolleschak, MD, Corinna Fahldieck, Satish Ranjan, Berend H Isermann, MD, Katrin Hebel, PhD, Monika Brunner-Weinzierl, PhD, Thomas Fischer, MD, Florian H Heidel, MD
Journal: Blood
Blood (2014) 124 (21): 1410.
https://doi.org/10.1182/blood.V124.21.1410.1410
Published: 2014
Journal Articles

A rare cause of lower back pain

Denise Wolleschak, Florian H. Heidel
Journal: Blood
Blood (2014) 124 (2): 165.
https://doi.org/10.1182/blood-2014-03-565713
Published: 2014
Journal Articles

FLT3-Kinase Inhibitors Quizartinib and Midostaurin Do Not Impair T-Cell Reactivity and Activation

Denise Wolleschak, MD, Thomas S. Mack, MSc, Florian Perner, Tina M Schnoeder, PhD, Marie-Christine Wagner, Stefanie Kliche, PhD, Burkhart Schraven, Satish Ranjan, Berend H. Isermann, MD, Daniel B. Lipka, MD, Thomas Fischer, MD, Florian H Heidel, MD
Journal: Blood
Blood (2012) 120 (21): 1045.
https://doi.org/10.1182/blood.V120.21.1045.1045
Published: 2012